Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19)

Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19)

Objective: to investigate the effectiveness of long-term oral administration of Actovegin in post-COVID patients with cognitive impairment (CI).Patients and methods. 444 patients (142 men, 302 women) with COVID-19 and CI participated in the study. One-half of the included participants – 222 patients...

Full description

Bibliographic Details
Main Author: V. A. Kutashov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2021-04-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
actovegin
bilateral polysegmental pneumonia
immunosuppression
coronavirus infection
covid-19
sars-cov-2
coronaviruses
nervous system
cytokine storm
cognitive impairment
Online Access:https://nnp.ima-press.net/nnp/article/view/1542

Internet

https://nnp.ima-press.net/nnp/article/view/1542

Similar Items